Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Statement [Abstract]
Grant revenue	$ 234,763	$ 87,586	$ 619,543	$ 183,025
Operating expenses:
Research and development	2,386,707	4,025,940	9,087,264	14,360,293
General and administrative	2,268,656	3,342,266	8,058,235	10,238,744
Total operating expenses	4,655,363	7,368,206	17,145,499	24,599,037
Loss from operations	(4,420,600)	(7,280,620)	(16,525,956)	(24,416,012)
Other income (expense):
Interest income	88,810	6,119	160,009	19,184
Change in fair value of note receivable	(77,454)		(114,870)
Total other income, net	11,356	6,119	45,139	19,184
Net loss	$ (4,409,244)	$ (7,274,501)	$ (16,480,817)	$ (24,396,828)
Net loss per share, basic (in Dollars per share)	$ (0.09)	$ (0.29)	$ (0.41)	$ (0.96)
Weighted average common shares outstanding, basic (in Shares)	47,441,693	25,451,691	39,983,825	25,399,352
Other comprehensive loss:
Foreign currency translation adjustments	$ (38,182)	$ (103,226)	$ (64,417)	$ (161,426)
Comprehensive loss	$ (4,447,426)	$ (7,377,727)	$ (16,545,234)	$ (24,558,254)